Trial record 1 of 2 for:    Atezolizumab and daratumumab
Previous Study | Return to List | Next Study

A Study of Daratumumab in Combination With Atezolizumab Compared With Atezolizumab Alone in Participants With Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (DARZALEX)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03023423
Recruitment Status : Active, not recruiting
First Posted : January 18, 2017
Last Update Posted : December 7, 2018
Genentech, Inc.
Information provided by (Responsible Party):
Janssen Research & Development, LLC

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : May 17, 2018
  Estimated Study Completion Date : April 24, 2019